Cargando…

Mechanisms of glucocorticoid induced osteoporosis

Detalles Bibliográficos
Autor principal:	Canalis, E
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833502/ http://dx.doi.org/10.1186/ar1372

Ejemplares similares

Glucocorticoid‐induced osteoporosis in rheumatic diseases
por: Pereira, Rosa Maria Rodrigues, et al.
Publicado: (2010)

Senile osteoporosis - two models of physiotherapy
por: Walusiak, M, et al.
Publicado: (2009)

9.1 Innate resistance of endothelial cells to the effects of glucocorticoids
por: Koenen, P, et al.
Publicado: (2008)

Treatment of childhood osteoporosis – current and future perspectives
por: Munns, Craig
Publicado: (2015)

Cell biology of synovial inflammation and secondary osteoporosis in rheumatoid arthritis
por: Tanaka, Y, et al.
Publicado: (2003)

OA11 Osteoporosis, denosumab, and hypocalcaemia in multimorbid renal impairment
por: Daurat, Jean-Luc, et al.
Publicado: (2023)

Glucocorticoid-induced osteoporosis
por: Briot, Karine, et al.
Publicado: (2015)

Glucocorticoid-induced Osteoporosis
por: Cherian, Kripa Elizabeth, et al.
Publicado: (2017)

Age variations of melatonin level and its hormesis; implications for AIS and osteoporosis
por: Grivas, TB, et al.
Publicado: (2009)

Updated evidence-based screening and treatment of osteoporosis in spinal cord injured patients
por: Maheronnaghsh, Radin, et al.
Publicado: (2012)

OA10 Pregnancy-associated osteoporosis - a rare subset of bone disease
por: Xia, Zhongyang, et al.
Publicado: (2023)

Corticosteroid insensitivity in severe asthma: impaired nuclear translocation of glucocorticoid receptor in airway smooth muscle cells
por: Bhavsar, Pankaj, et al.
Publicado: (2013)

Advances in Glucocorticoid-Induced Osteoporosis
por: den Uyl, Debby, et al.
Publicado: (2011)

A4 PREDNISOLONE, A GLUCOCORTICOID WIDELY USED FOR TREATMENT OF IBD, ENHANCES A HUMAN INTERLEUKIN-4-ACTIVATED MACROPHAGE PHENOTYPE
por: Deshpande, R S, et al.
Publicado: (2023)

Osteoporosis in children with chronic illness: lessons from natural history studies that guide clinical practice
por: Ward, Leanne M
Publicado: (2015)

The HIV-1 Vpr and glucocorticoid receptor complex is a gain of function interaction that prevents the nuclear localization of PARP-1
por: Muthumani, Karuppiah, et al.
Publicado: (2006)

7.6 Long-term treatment with glucocorticoids and low bone mass: a longitudinal study in 266 children and adolescents
por: Biggioggero, M, et al.
Publicado: (2008)

Glucocorticoid-induced osteoporosis: an update
por: Compston, Juliet
Publicado: (2018)

Update on Glucocorticoid Induced Osteoporosis
por: Cho, Soo-Kyung, et al.
Publicado: (2021)

Mechanisms of Aβ induced synaptic toxicity
por: Koo, Edward H
Publicado: (2013)

Cytokine induced molecular mechanisms of bone/cartilage metabolism
por: Schett, Georg
Publicado: (2011)

OA07 A case of severe osteoporosis treated with teriparatide following the development of bilateral atypical femoral fractures due to IV zoledronic acid
por: Rosa, Chamith, et al.
Publicado: (2023)

Bisphosphonates and glucocorticoid-induced osteoporosis: cons
por: Lems, Willem F., et al.
Publicado: (2015)

Linking glucocorticoid-induced osteoporosis to osteoimmunology
por: von Gunten, Stephan, et al.
Publicado: (2020)

Zebrafish models for glucocorticoid-induced osteoporosis
por: Lin, Wen-Ying, et al.
Publicado: (2022)

Potential mechanisms whereby estrogens induce breast cancer in women
por: Santen, RJ, et al.
Publicado: (2005)

O03 - Expression of pulmonary surfactant protein D (SP-D) and interleukin 13 in the serum of atopic and non-atopic severe pediatric asthmatics: effects of glucocorticoid and sodium cromoglycate treatment
por: Gemou-Engesaeth, Vasiliki, et al.
Publicado: (2014)

Mechanisms of resistance against Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts
por: Pap, T, et al.
Publicado: (2003)

Mechanism for XMRV neurotoxicity
por: Vaughan, Andrew E, et al.
Publicado: (2011)

Management of glucocorticoids-induced osteoporosis: role of teriparatide
por: Migliaccio, Silvia, et al.
Publicado: (2009)

Role of teriparatide in treatment of glucocorticoid-induced osteoporosis
por: Lau, Arthur N, et al.
Publicado: (2010)

The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis
por: Hasegawa, Eriko, et al.
Publicado: (2018)

Glucocorticoid-Induced Osteoporosis: Why Kids Are Different
por: Ward, Leanne M.
Publicado: (2020)

The critical role of T cells in glucocorticoid-induced osteoporosis
por: Song, Lin, et al.
Publicado: (2020)

The molecular etiology and treatment of glucocorticoid-induced osteoporosis
por: Peng, Cheng-Huan, et al.
Publicado: (2021)

Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients
por: Valeyrie-Allanore, Laurence, et al.
Publicado: (2014)

Core stemness mechanisms revealed through homology
por: Koeva, Martina, et al.
Publicado: (2009)

Pregnancy outcomes of women with mechanical heart valves
por: Kucuker, A, et al.
Publicado: (2013)

Mechanisms of pain in arthritis
por: Schaible, H-G
Publicado: (2004)

Autoimmune diabetes: mechanisms
por: Cooke, A
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_8folc29s5uv7l240i49ieggb8j